RankAlpha logo
Back to Rankings

NTLA

Intellia TherapeuticsC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
NTLA vs peer average
60/100
NTLA vs. peer average (C vs. D)
Grade spread
C 5 · D 5 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

SANA is the first available peer comparator.

Closest small-cap genomic-medicine risk appetite comp in the packet, useful for financing tolerance and platform-credibility context, though it is less clinically de-risked than Intellia.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerSANASana Biotechnology
NTLA
Intellia Therapeutics
SANA
Sana Biotechnology
Grade
C
C
Momentum
37
63
Value
41
41
Sentiment
79
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs SANA

NTLA / SANA
Grade Position
In line
NTLA vs. peer average (C vs. D)
60/100
Momentum
37
SANA
Value
41
NTLA
Sentiment
79
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs NTLA
1
SANA
SANA
C
60/100
Even
2
REGN
REGN
C
60/100
Even
3
OMER
OMER
D
40/100
+1
4
VIR
Vir Biotechnology Inc Common
C
60/100
Even
5
INVA
Innoviva Inc Common
C
60/100
Even
SANA is the first peer returned for this comparison set.